FI46259C - Menetelmä uusien terapeuttisesti arvokkaiden 11-alkyylioksi-1,2,3,10,1 1,11a-heksahydro-2-etyylideeni-7-metoksi-8-hydroksi-5H-pyrrolo/2,1-c/ /1,4/bentsodiatsepin-5-onien valmistamiseksi. - Google Patents

Menetelmä uusien terapeuttisesti arvokkaiden 11-alkyylioksi-1,2,3,10,1 1,11a-heksahydro-2-etyylideeni-7-metoksi-8-hydroksi-5H-pyrrolo/2,1-c/ /1,4/bentsodiatsepin-5-onien valmistamiseksi.

Info

Publication number
FI46259C
FI46259C FI693710A FI371069A FI46259C FI 46259 C FI46259 C FI 46259C FI 693710 A FI693710 A FI 693710A FI 371069 A FI371069 A FI 371069A FI 46259 C FI46259 C FI 46259C
Authority
FI
Finland
Prior art keywords
benzodiazepin
alkyloxy
pyrrolo
hexahydro
ethylidene
Prior art date
Application number
FI693710A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI46259B (enExample
Inventor
Arima
Tamura
Sakai
Kohsaka
Kariyone
Yazawa
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP44050780A external-priority patent/JPS4843755B1/ja
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of FI46259B publication Critical patent/FI46259B/fi
Publication of FI46259C publication Critical patent/FI46259C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI693710A 1968-12-30 1969-12-22 Menetelmä uusien terapeuttisesti arvokkaiden 11-alkyylioksi-1,2,3,10,1 1,11a-heksahydro-2-etyylideeni-7-metoksi-8-hydroksi-5H-pyrrolo/2,1-c/ /1,4/bentsodiatsepin-5-onien valmistamiseksi. FI46259C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8368 1968-12-30
JP44050780A JPS4843755B1 (enExample) 1969-06-26 1969-06-26

Publications (2)

Publication Number Publication Date
FI46259B FI46259B (enExample) 1972-10-31
FI46259C true FI46259C (fi) 1973-02-12

Family

ID=26332992

Family Applications (1)

Application Number Title Priority Date Filing Date
FI693710A FI46259C (fi) 1968-12-30 1969-12-22 Menetelmä uusien terapeuttisesti arvokkaiden 11-alkyylioksi-1,2,3,10,1 1,11a-heksahydro-2-etyylideeni-7-metoksi-8-hydroksi-5H-pyrrolo/2,1-c/ /1,4/bentsodiatsepin-5-onien valmistamiseksi.

Country Status (6)

Country Link
ES (1) ES375013A1 (enExample)
FI (1) FI46259C (enExample)
GB (1) GB1299198A (enExample)
IE (1) IE33906B1 (enExample)
IL (1) IL33558A (enExample)
RO (1) RO55813A (enExample)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464467A (en) * 1982-07-26 1984-08-07 Bristol-Myers Company Antitumor antibiotics produced by new streptomyces
DE69925133T2 (de) * 1998-08-27 2006-01-19 Spirogen Ltd., Ryde Pyrrolobenzodiazepine
GB9818732D0 (en) 1998-08-27 1998-10-21 Univ Portsmouth Collection of compounds
GB9818730D0 (en) 1998-08-27 1998-10-21 Univ Portsmouth Collections of compounds
US6909006B1 (en) 1999-08-27 2005-06-21 Spirogen Limited Cyclopropylindole derivatives
GB0226593D0 (en) 2002-11-14 2002-12-24 Consultants Ltd Compounds
GB0321295D0 (en) 2003-09-11 2003-10-15 Spirogen Ltd Synthesis of protected pyrrolobenzodiazepines
WO2005085251A1 (en) 2004-03-01 2005-09-15 Spirogen Limited 11-hydroxy-5h-pyrrolo[2,1-c][1,4]benzodiazepin-5-one derivatives as key intermediates for the preparation of c2 substituted pyrrolobenzodiazepines
GB0404577D0 (en) 2004-03-01 2004-04-07 Spirogen Ltd Pyrrolobenzodiazepines
WO2005085260A1 (en) 2004-03-09 2005-09-15 Spirogen Limited Pyrrolobenzodiazepines
GB0819095D0 (en) 2008-10-17 2008-11-26 Spirogen Ltd Pyrrolobenzodiazepines
JP5875083B2 (ja) 2010-04-15 2016-03-02 メディミューン リミテッド 増殖性疾患治療用ピロロベンゾジアゼピン
GB201006340D0 (en) 2010-04-15 2010-06-02 Spirogen Ltd Synthesis method and intermediates
CA2795349C (en) 2010-04-15 2016-11-29 Seattle Genetics, Inc. Targeted pyrrolobenzodiazepine conjugates
SG11201400770SA (en) 2011-09-20 2014-04-28 Spirogen Sarl Pyrrolobenzodiazepines as unsymmetrical dimeric pbd compounds for inclusion in targeted conjugates
AU2012322932B2 (en) 2011-10-14 2016-11-10 Medimmune Limited Pyrrolobenzodiazepines
BR112014009070B1 (pt) 2011-10-14 2021-11-23 Medimmune Limited Método de síntese e intermediários úteis na preparação de pirrolobenzo-diazepinas
CA2850373C (en) 2011-10-14 2019-07-16 Seattle Genetics, Inc. Pyrrolobenzodiazepines and targeted conjugates
EP2751111B1 (en) 2011-10-14 2017-04-26 MedImmune Limited Asymmetrical bis-(5H-Pyrrolo[2,1-c][1,4]benzodiazepin-5-one) derivatives for the treatment of proliferative or autoimmune diseases
CN103997893B (zh) 2011-10-14 2019-04-12 西雅图基因公司 吡咯并苯并二氮杂卓和靶向结合物
EP2906297B1 (en) 2012-10-12 2017-12-06 ADC Therapeutics SA Pyrrolobenzodiazepine-antibody conjugates
ES2680153T3 (es) 2012-10-12 2018-09-04 Adc Therapeutics Sa Conjugados de anticuerpos anti-PSMA-pirrolobenzodiazepinas
JP6392765B2 (ja) 2012-10-12 2018-09-19 エイディーシー・セラピューティクス・エス・アーＡｄｃ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｓａ ピロロベンゾジアゼピン−抗体結合体
EP2906249B1 (en) 2012-10-12 2018-06-27 MedImmune Limited Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation
EP2906296B1 (en) 2012-10-12 2018-03-21 ADC Therapeutics SA Pyrrolobenzodiazepine-antibody conjugates
HRP20190366T1 (hr) 2012-10-12 2019-04-19 Medimmune Limited Pirolobenzodiazepini i njihovi konjugati
RS57694B1 (sr) 2012-10-12 2018-11-30 Adc Therapeutics Sa Pirolobenzodiazepin - anti-psma konjugati antitela
HRP20182129T1 (hr) 2012-10-12 2019-02-08 Adc Therapeutics Sa Konjugati protutijelo - pirolobenzodiazepin
MX338711B (es) 2012-10-12 2016-04-28 Medimmune Ltd Pirrolobenzodiazepinas y conjugados de las mismas.
WO2015052535A1 (en) 2013-10-11 2015-04-16 Spirogen Sàrl Pyrrolobenzodiazepine-antibody conjugates
GB201317981D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
EP3054983B1 (en) 2013-10-11 2019-03-20 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
WO2015052534A1 (en) 2013-10-11 2015-04-16 Spirogen Sàrl Pyrrolobenzodiazepine-antibody conjugates
GB201416112D0 (en) 2014-09-12 2014-10-29 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
CN107148285B (zh) 2014-11-25 2022-01-04 Adc治疗股份有限公司 吡咯并苯并二氮杂䓬-抗体缀合物
GB201506402D0 (en) 2015-04-15 2015-05-27 Berkel Patricius H C Van And Howard Philip W Site-specific antibody-drug conjugates
GB201506411D0 (en) 2015-04-15 2015-05-27 Bergenbio As Humanized anti-axl antibodies
GB201601431D0 (en) 2016-01-26 2016-03-09 Medimmune Ltd Pyrrolobenzodiazepines
GB201602359D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201602356D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201607478D0 (en) 2016-04-29 2016-06-15 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201617466D0 (en) 2016-10-14 2016-11-30 Medimmune Ltd Pyrrolobenzodiazepine conjugates
RS61795B1 (sr) 2017-02-08 2021-06-30 Adc Therapeutics Sa Konjugati pirolobenzodiazepin antitela
GB201702031D0 (en) 2017-02-08 2017-03-22 Medlmmune Ltd Pyrrolobenzodiazepine-antibody conjugates
CN110582505B (zh) 2017-04-18 2021-04-02 免疫医疗有限公司 吡咯并苯并二氮杂*缀合物
WO2018193102A1 (en) 2017-04-20 2018-10-25 Adc Therapeutics Sa Combination therapy with an anti-axl antibody-drug conjugate
CA3064804A1 (en) 2017-06-14 2018-12-20 Adc Therapeutics Sa Dosage regimes for the administration of an anti-cd19 adc
KR102270107B1 (ko) 2017-08-18 2021-06-30 메디뮨 리미티드 피롤로벤조디아제핀 컨쥬게이트
GB201803342D0 (en) 2018-03-01 2018-04-18 Medimmune Ltd Methods
GB201806022D0 (en) 2018-04-12 2018-05-30 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
CN113631560B (zh) 2019-03-15 2025-02-18 麦迪穆有限责任公司 氮杂环丁烷并苯并二氮杂䓬二聚体和用于治疗癌症的包含它们的缀合物

Also Published As

Publication number Publication date
IE33906B1 (en) 1974-12-11
IL33558A0 (en) 1970-04-20
GB1299198A (en) 1972-12-06
IL33558A (en) 1973-10-25
ES375013A1 (es) 1972-03-01
IE33906L (en) 1970-06-30
FI46259B (enExample) 1972-10-31
RO55813A (enExample) 1974-02-01

Similar Documents

Publication Publication Date Title
FI46259C (fi) Menetelmä uusien terapeuttisesti arvokkaiden 11-alkyylioksi-1,2,3,10,1 1,11a-heksahydro-2-etyylideeni-7-metoksi-8-hydroksi-5H-pyrrolo/2,1-c/ /1,4/bentsodiatsepin-5-onien valmistamiseksi.
FI51347C (fi) Menetelmä 1-substituoitujen-3- ja -4-aroyylipiperidiinien valmistamise ksi.
FI52574C (fi) Menetelmä farmakologisesti arvokkaiden substituoitujen N-allyyli-2-fen yyliamino-imidatsoliinien-(2) valmistamiseksi.
DK132174B (da) Analogifremgangsmåde til fremstilling af 2,4-diamino-5-benzylpyrimider.
FI49503C (fi) Analogiamenetelmä 1,2,3,4-tetrahydro-4-fenyyli-isokinoliinijohdannaist en valmistamiseksi.
FI48588C (fi) Analogiamenetelmä terapeuttisesti vaikuttavien 3,4-dihydroisokinoliini johdannaisten valmistamiseksi.
DK123715B (da) Fremgangsmåde til fremstilling af 4'-demethylepipodophyllotoxin-β-D-alkylidenglucosider.
BG17560A3 (bg) Метод за получаане на 4,20, 22- буфатриеноли- драмнозид- етери
DK140842B (da) Fremgangsmåde til fremstilling af 8,9-didebydro-10alfa-alkoxy-ergolener.
RO71305A (ro) Procedeu pentru prepararea d-halo-6-metil-2,8-ciano-(carboxamido)-ergoline
BG22815A3 (bg) Метод за получаване на 2,6-диамино-дихидропиридини
DK127812B (da) Analogifremgangsmåde til fremstilling af 3,5-dibrom-zearalan.
DK127778B (da) Fremgangsmåde til fremstilling af 3',4'-dideoxy-kenamycin B.
BG19178A3 (bg) Метод за получаване на 8-субституирани-5н-пироло-(2,1-с) 1,4 бензодиазепин-5-они
FI44625C (fi) Menetelmä uusien terapeuttisesti arvokkaiden d-treo-1-fenyyli-2-amino-1,3-propaanidiolijohdannaisten valmistamiseksi
FI50710C (fi) Menetelmä 1,4-bentsodiatsepiinien valmistamiseksi.
AR214033A1 (es) Procedimiento para preparar 1,2,3,4,5,6-hexahidro-2,6-metano-3-benzazocinas
RO67383A (ro) Procedeu pentru prepararea unor 2,4-diamino-5-benzilpirimidine
FI46723C (fi) Menetelmä 1,18-dimetyyli-5alfa-H-androst-1-eenijohdannaisten valmistam iseksi.
FI52225C (fi) Menetelmä terapeuttisesti käytettävien 15alfa,16alfa-metyleeni-4-estre eni-17beta-olien valmistamiseksi.
FI47181C (fi) Menetelmä tulehdusta estävien 2-kloori-6alfa,9alfa,11beta-trihalogeeni -16alfa-metyyli-pregnadieenin valmistamiseksi.
DK121440B (da) Analogifremgangsmåde til fremstilling af 2,4-bis-morpholino- eller-thiomorpholino-5-carbalkoxy-pyrimidiner.
DK129041B (da) Analogifremgangsmåde til fremstilling af 6,21-dihalogen-3,16α,17α-trihydroxy-pregna-4,6-dien-20-oner.
BG15557A3 (bg) Метод за получаване на n-ацил-1,2-дикарбонил-фенил- хидразони
FI48928C (fi) Menetelmä (-)-norskopolamiinin valmistamiseksi.